cells without this genetic endowment and still bear no direct relationship to the cystic fibrosis defect.
Cultured cells with mutant genotypes invariably show some culture deviations. Such is the case also for the cultured cystic fibrosis cell (Table) . All the features of the cultured cystic fibrosis cell, so far described, have not been demonstrated to be specific for the cystic fibrosis gene. Unfortunately such observations probably do not lead us closer to an understanding of the basic defect in cystic fibrosis. Danes and Beam (1969b) Heterogeneity in staining meta- Danes (1972) ; chromasia and ametachromasia Nadler et al (1969) Variable mucopolysaccharide content Danes and Bearn (1969b;  intra-and extracellular 1969c); Matalon and Dorfman (1968) Increased glycogen storage Pallavicini et al (1970) Decreased collagen synthesis and Houck and Sharma (1970) collagenolysis Longer generation time Houck and Sharma (1970) Increase in lysosomes number and
Bartman et al (1970) size
Alteration in total hexosaminidase and Conover et al (1973c) ratio of isoenzymes A to B Cystic fibrosis factor activity (CFFA) Danes (1972) A recent hypothesis has been that there is a humoral factor in body fluids which alters cellular function in the cystic fibrosis cell (Spock et al, 1967) . A substance (cystic fibrosis factor) has been recognized in the serum and medium from cultured cells established from the majority of cystic fibrosis patients which alters the motility of rabbit tracheal cilia (Spock et al, 1967); Conover et al, 1973a ) and oyster cilia (Danes, 1972; Danes and Beam, 1972; Bowman et al, 1973) . Although such a factor may by causally related to the pathological changes seen in cystic fibrosis (Farber, 1945; The abnormalities assigned to the cultured cystic fibrosis cell (Table) have all been considered at some time for use as a possible assay for the heterozygote. None has been proven specific for the cystic fibrosis gene and the reliability and reproducibility of their assays sufficient to warrant consideration for use in detecting the cystic fibrosis gene in the general population (Wood and di Sant'Agnese, 1973) .
Cystic fibrosis factor has been widely proposed for use in screening for the heterozygote and thus the most thoroughly studied. At present there are two bioassays (rabbit tracheal ciliary assay (Spock et al, 1967; Conover et al, 1973b) and oyster cilia test (Bowman et al, 1969) ). The developers of both assay systems agree that there are technical problems which limit the use of their assay systems to basic research aims but they do not agree on their reproducibility and significance. Although numerous biological fluids have been tested using one of these two bioassays, there is, at present, no agreement on which fluid should be used as the test sample and in which bioassay (Wood and di Sant'Agnese, 1973) .
The direction of cystic fibrosis research using cultured cells has become diffuse. It has become a 'rush' to describe any abnormality (morphological, metabolic, or immunological) of the cultured cystic fibrosis cell. One way to reduce the randomness of this search is to test any hypothesis on cystic fibrosis families rather than on individuals. When a cell abnormality may be of possible use in screening for the gene, it is suggested that samples from families rather than individual cystic fibrosis patients and normal subjects be used to establish its specificity for the cystic fibrosis gene. As cystic fibrosis is an autosomal recessive disorder, it should be possible to trace a cellular abnormality, specific for the gene, through consecutive generations and to demonstrate its segregation.
The cultured cystic fibrosis cell will eventually 'reveal' its basic defect. Until then, the more that is learned about the expression of the cultured cystic fibrosis cell should enhance our understanding of the cellular pathology in vivo.
